Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands

International Journal of Cancer

Volumn 139, Issue 3, 2016, Pages 574-583

  Van Dijk, Boukje A C ^a,b   Brands, Marieke T ^c   Geurts, Sandra M E ^c   Merkx, Matthias A W ^c   Roodenburg, Jan L N ^b  

^a Netherlands Comprehensive Cancer Organisation ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

incidence; mortality; oral cavity cancer; relative survival; treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DISEASE SURVEILLANCE; FEMALE; GINGIVA TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NETHERLANDS; ORAL SURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TONGUE CANCER; TREND STUDY; INCIDENCE; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; MULTIMODALITY CANCER THERAPY; REGISTER; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84963542340     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30107     Document Type: Article

References (48)

1. Braakhuis BJ, Visser O, Leemans CR., Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 2009; 45: e85-9.
2. Nederlandse Kankerregistratie. Cijfers over kanker in Nederland. Available at: http://www.cijfersoverkanker.nl/?language=en [Last accessed: 25-01-2016].
3. Braakhuis BJ, Leemans CR, Visser O., Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 2014; 50: 670-5.
4. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al., Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550-9.
5. Karim-Kos HE, de Vries E, Soerjomataram I, et al., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
6. Hashibe M, Brennan P, Chuang SC, et al., Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18: 541-50.
7. Wensing BM, Deserno WM, de Bondt RB, et al., Diagnostic value of magnetic resonance lymphography in preoperative staging of clinically negative necks in squamous cell carcinoma of the oral cavity: a pilot study. Oral Oncol 2011; 47: 1079-84.
8. Kelner N, Vartanian JG, Pinto CA, et al., Does elective neck dissection in T1/T2 carcinoma of the oral tongue and floor of the mouth influence recurrence and survival rates? Br J Oral Maxillofac Surg 2014; 52: 590-7.
9. Fasunla AJ, Greene BH, Timmesfeld N, et al., A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011; 47: 320-4.
10. Cooper JS, Pajak TF, Forastiere AA, et al., Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44.
11. Richtlijn Mondholte- en Orofarynxcarcinoom. Nederlandse Werkgroep Hoofd-Halstumoren, 2004.
12. Meulenpas JM, Kiemeney LALM., Kanker in Nederland tot 2020. Trends en prognoses. KWF Kankerbestrijding, 2011.
13. van der Sanden GA, Coebergh JW, Schouten LJ, et al., Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995; 31A: 1822-9.
14. Fritz A, Percy C, Jack A, et al., eds. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization, 2000. 240 p.
15. Kim HJ, Fay MP, Feuer EJ, et al., Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
16. Royston P., PTREND: Stata module for trend analysis for proportions. Available at: https://ideas.repec.org/c/boc/bocode/s426101.html [Last accessed: 25-01-2016].
17. Dickman PW, Coviello E, Hills M., Estimating and modelling relative survival. The Stata J 2013; 1-25.
18. Dickman PW, Sloggett A, Hills M, et al., Regression models for relative survival. Stat Med 2004; 23: 51-64.
19. Warnakulasuriya S., Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
20. van Laar MW, Cruts AAN, Verdurmen JEE, et al., Nationale Drug Monitor Jaarbericht 2007. Trimbos-instituut, 2008.
21. Cruts AAN MR, Croes EA, Ketelaars APM, et al., Nationale Drug Monitor Jaarbericht 2013/2014. Trimbos-instituut, 2014.
22. Janssen F, van Poppel F., The adoption of smoking and its effect on the mortality gender gap in Netherlands: a historical perspective. Biomed Res Int 2015; 2015: 370274.
23. Karim-Kos HE, Kiemeney LA, Louwman MW, et al., Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation. Int J Cancer 2012; 130: 2981-89.
24. van Dijk BA, Karim-Kos HE, Coebergh JW, et al., Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer 2014; 134: 674-81.
25. Karim-Kos HE, Janssen-Heijnen ML, van Iersel CA, et al., The beginning of the end of the lung cancer epidemic in Dutch women? Int J Cancer 2008; 123: 1472-5.
26. Gillison ML, Chaturvedi AK, Anderson WF, et al., Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol 2015; 33: 3235-42.
27. Mirghani H, Amen F, Moreau F, et al., Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncol 2015; 51: 229-36.
28. van Monsjou HS, Schaapveld M, van den Brekel MW, et al., The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change? Oral Oncol 2015; 51: 901-7.
29. Gooi Z, Chan JY, Fakhry C., The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope 2016; 126:894-900.
30. Doobaree IU, Landis SH, Linklater KM, et al., Head and neck cancer in South East England between 1995-1999 and 2000-2004: an estimation of incidence and distribution by site, stage and histological type. Oral Oncol 2009; 45: 809-14.
31. Rafiq R, Brocklehurst P, Rogers SN., Effect of Mouth Cancer Awareness Week on urgent suspected head and neck cancer referrals. Br J Oral Maxillofac Surg 2013; 51: e183-5.
32. Luryi AL, Yarbrough WG, Niccolai LM, et al., Public awareness of head and neck cancers: a cross-sectional survey. JAMA Otolaryngol Head Neck Surg 2014; 140: 639-46.
33. Hvidberg L, Pedersen AF, Wulff CN, et al., Cancer awareness and socio-economic position: results from a population-based study in Denmark. BMC Cancer 2014; 14: 581.
34. Montero PH, Yu C, Palmer FL, et al., Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer 2014; 120: 214-21.
35. Arya S, Rane P, Deshmukh A., Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clin Radiol 2014; 69: 916-30.
36. Siegel RL, Miller KD, Jemal A., Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
37. Boje CR., Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma: a systematic review. Radiother Oncol 2014; 110: 81-90.
38. Boje CR, Dalton SO, Primdahl H, et al., Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol 2014; 110: 91-7.
39. Rose BS, Jeong JH, Nath SK, et al., Population-based study of competing mortality in head and neck cancer. J Clin Oncol 2011; 29: 3503-09.
40. van Leersum NJ, Janssen-Heijnen ML, Wouters MW, et al., Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995-2010. Int J Cancer 2013; 132: 2157-63.
41. Van Dijk BA, Gatta G, Capocaccia R, et al., Rare cancers of the head and neck area in Europe. Eur J Cancer 2012; 48: 783-96.
42. Gatta G, Botta L, Sanchez MJ, et al., Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer 2015; 51: 2130-43.
43. Cannady SB, Rosenthal EL, Knott PD, et al., Free tissue transfer for head and neck reconstruction: a contemporary review. JAMA Facial Plast Surg 2014; 16: 367-73.
44. Cooper JS, Pajak TF, Forastiere AA, et al., Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44.
45. Bernier J, Domenge C, Ozsahin M, et al., Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-52.
46. Hoofd-halstumoren NW. Richtlijn Mondholte- en Orofarynxcarcinoom ed. Alphen aan den Rijn: Van Zuiden communications B.V., 2004.
47. Gonzalez-Garcia R, Naval-Gias L, Roman-Romero L, et al., Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head & Neck 2009; 31: 1168-80.
48. Liu CH, Chen HJ, Wang PC, et al., Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone. Kaohsiung J Med Sci 2013; 29: 554-9.